One
simply can’t seem to keep the Ranbaxy brothers out of the news. Malvinder has
been in the news for negotiating the Ranbaxy sale to Daiichi-Sankyo and more
recently for being ousted as the CEO of Ranbaxy thanks to a whole bunch of
problems from falling stock prices to hassles with the United States Food and
Drug Administration. The recent news of the Ranbaxy brothers acquiring ten
hospitals of Wockhardt for an
estimated sum of 910 Crore rupees is a definite piece of good news.
In
fact it’s the best piece of news which has come the way of the Ranbaxy brothers
in the recent months and from an investor point of view, the Fortis stock is looking extremely
attractive as a long term investment.
